Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Communiqué de presse : Approbation du Sarclisa dans l’UE – premier anti-CD38 en association avec le schéma VRd de référence pour le traitement du...
Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat...
Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible...
Press Release: Opella reaches study milestone for Cialis Opella reaches study milestone for Cialis Paris, January 21, 2025. Opella, Sanofi’s...
Opella reaches study milestone for Cialis Paris, January 21, 2025. Opella, Sanofi’s Consumer Healthcare...
Communiqué de presse : Opella : étape clé franchie pour l’étude consacrée au Cialis Opella : étape clé franchie pour l’étude consacrée au Cialis...
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Novembre 2024 Informations relatives au nombre total de droits de...
Sanofi: Information concerning the total number of voting rights and shares – November 2024 Information concerning the total number of voting...
Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory...
Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III...
Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma New Sarclisa...
New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma...
Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de...
Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation...
Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지